Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
February 11, 2010

Qiagen to Distribute Celera’s ResPlex II Multiplex Assay for Respiratory Pathogens

  • Qiagen negotiated exclusive, worldwide distribution rights to Celera’s next-generation ResPlex II multiplex assay for the detection of respiratory pathogens. The new assay detects 19 different pathogens and is designed for use with the Luminex LiquiChip 100 and 200 instrument platforms, for which Qiagen is also a partner. The test has yet to be submitted for regulatory approval in the U.S. and Europe.

Related content

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.